Alpana Naresh, Ph.D.

Executive Director, CMC Operations at Harpoon Therapeutics Inc., a subsidiary of Merck & Co., Inc.

Speaker

Alpana Naresh, Ph.D. is Executive Director, CMC Operations at Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA). She is responsible for technology transfer from Harpoon to CDMOs. She manages development and manufacturing including analytics for release and stability of Drug substance and Drug product at various CDMOs/CMOs and CROs. She is responsible for regulatory filing for CMC modules. Prior to joining Harpoon, Alpana was Principal Scientist at Boehringer Ingelheim, Fremont. Her team was responsible for development of Drug Substance for early and late stage products. She has also worked at JSR Life Sciences, Sutro Biopharma, and Genitope in various roles focused on process development of biotherapeutics.